HG106, a potent SLC7A11 inhibitor, leads to enhanced ROS generation, ER stress, and ultimately growth arrest specifically in KRAS-mutant lung adenocarcinoma (LUAD).
Oncotarget, December 1, 2023, 957-969
Journal of Lipid Research, August 12, 2025, 100876